Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Individuals with high anti-citrullinated protein antibody (ACPA) titers have an increased risk of developing rheumatoid arthritis (RA). Although our knowledge of the generation and production of ACPAs has continuously advanced during the past decade, our understanding on the pathogenic mechanisms of how ACPAs interact with immune cells to trigger articular inflammation is relatively limited. Citrullination disorders drive the generation and maintenance of ACPAs, with profound clinical significance in patients with RA. The loss of tolerance to citrullinated proteins, however, is essential for ACPAs to exert their pathogenicity. N-linked glycosylation, cross-reactivity and the structural interactions of ACPAs with their citrullinated antigens further direct their biological functions. Although questions remain in the pathogenicity of ACPAs acting as agonists for a receptor-mediated response, immune complex (IC) formation, complement system activation, crystallizable fragment gamma receptor (FcγR) activation, cross-reactivity to joint cartilage and neutrophil extracellular trap (NET)-related mechanisms have all been suggested recently. This paper presents a critical review of the characteristics and possible biological effects and mechanisms of the immunopathogenesis of ACPAs in patients with RA.
Pareek A, Mehlawat K, Tripathi K, Pareek A, Chaudhary S, Ratan Y Front Immunol. 2025; 15():1510693.
PMID: 39759520 PMC: 11695321. DOI: 10.3389/fimmu.2024.1510693.
Tiwari E, Shrimankar D, Maindarkar M, Bhagawati M, Kaur J, Singh I Rheumatol Int. 2025; 45(1):14.
PMID: 39745536 DOI: 10.1007/s00296-024-05756-5.
The role of autoantibodies in bridging obesity, aging, and immunosenescence.
Valentino T, Chen N, Makhijani P, Khan S, Winer S, Revelo X Immun Ageing. 2024; 21(1):85.
PMID: 39616399 PMC: 11607830. DOI: 10.1186/s12979-024-00489-2.
Overview of mechanisms and novel therapies on rheumatoid arthritis from a cellular perspective.
Han P, Liu X, He J, Han L, Li J Front Immunol. 2024; 15:1461756.
PMID: 39376556 PMC: 11456432. DOI: 10.3389/fimmu.2024.1461756.
The emerging role of neutrophil extracellular traps in the progression of rheumatoid arthritis.
Chen J, Cao Y, Xiao J, Hong Y, Zhu Y Front Immunol. 2024; 15:1438272.
PMID: 39221253 PMC: 11361965. DOI: 10.3389/fimmu.2024.1438272.